Hansoh Pharmaceutical: no change to share capital in november

Hansoh Pharmaceutical Group Company Limited's monthly return for November 2025 indicates a stable capital structure. The company’s authorized/registered share capital remained at HK$200,000, consisting of 20,000,000,000 ordinary shares with a par value of HK$0.00001 each. The total number of issued ordinary shares also held steady at 6,055,150,070, with no movements reported for the month.

The report further confirmed no changes in the company's treasury shares or any share options, warrants, or other agreements to issue shares. The number of shares which may be issued pursuant to outstanding zero coupon convertible bonds due 2026, issued on January 22, 2021, remained at 735,363. The principal amount of these convertible bonds stood at $5,378,000 as of month-end, with a subscription/conversion price of HK$56.7.